Hemex
Europe, Basel-Landschaft, Switzerland, Liestal
Description
Hemex AG helps its clients to develop pharmaceuticals and medical devices.
Investor Profile
Hemex has backed more than 14 startups, with 1 new investments in the last 12 months alone. The firm has led 6 rounds, about 43% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in Switzerland, Sweden.
- Strong thematic focus on Health Care, Biotechnology, Life Science.
- Led 1 rounds in the past year.
Stage Focus
- Seed (43%)
- Series A (21%)
- Series B (14%)
- Convertible Note (7%)
- Pre Seed (7%)
- Series Unknown (7%)
Country Focus
- Switzerland (93%)
- Sweden (7%)
Industry Focus
- Health Care
- Biotechnology
- Life Science
- Medical Device
- Medical
- Hardware
- Information Technology
- Therapeutics
- Artificial Intelligence (Ai)
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
